Workflow
微脉公司递表港交所,专注“AI+全病程管理服务”
Sou Hu Cai Jing·2025-06-27 08:36

Company Overview - MicroPulse has officially submitted its listing application to the Hong Kong Stock Exchange on June 27, with China Merchants Securities International and Deutsche Bank serving as joint sponsors [2] - Headquartered in Hangzhou, MicroPulse is a pioneer and leader in AI-enabled full-course management services in China, aiming to enhance the healthcare service value chain by connecting hospitals, doctors, and patients [2] Market Position - Based on projected revenue for 2024, MicroPulse ranks among the top three full-course management service providers in China and is the largest AI-enabled patient-centric service provider in the country [2] - The company covers the entire health management process for patients, from pre-treatment to post-treatment, and is one of the few official managed health management partners of public medical institutions in China, giving it a unique advantage in the industry [2] Service Model - MicroPulse has established a multidisciplinary health management team by directly signing contracts with public hospitals to meet the health and disease assessment needs of patients at different stages [2] - This model allows for the development of a multi-level, multi-population, and multi-disease full-course management service system in collaboration with hospitals, providing comprehensive and continuous healthcare services [2] Financial Performance - As of the latest feasible date, MicroPulse has partnered with 157 hospitals and over 4,700 cooperative hospitals, serving approximately 200,000 patients in full-course management during the track record period [3] - Financially, MicroPulse reported revenues of approximately 512 million RMB, 628 million RMB, and 653 million RMB for the fiscal years 2022, 2023, and 2024, respectively, with corresponding losses of approximately 414 million RMB, 150 million RMB, and 193 million RMB [3]